BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 30808296)

  • 1. Single-center evaluation of a next generation fully repositionable and retrievable transcatheter aortic valve replacement.
    Berntorp K; Koul S; Nozohoor S; Harnek J; Bjursten H; Götberg M
    BMC Cardiovasc Disord; 2019 Feb; 19(1):44. PubMed ID: 30808296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of a Repositionable and Fully Retrievable Aortic Valve in Routine Clinical Practice: The RESPOND Study and RESPOND Extension Cohort.
    Van Mieghem NM; Wöhrle J; Hildick-Smith D; Bleiziffer S; Blackman DJ; Abdel-Wahab M; Gerckens U; Linke A; Ince H; Wenaweser P; Allocco DJ; Meredith IT; Falk V
    JACC Cardiovasc Interv; 2019 Jan; 12(1):38-49. PubMed ID: 30621976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcome With the Repositionable and Retrievable Boston Scientific Lotus Valve Compared With the Balloon-Expandable Edwards Sapien 3 Valve in Patients Undergoing Transfemoral Aortic Valve Replacement.
    Seeger J; Gonska B; Rottbauer W; Wöhrle J
    Circ Cardiovasc Interv; 2017 Jun; 10(6):. PubMed ID: 28566290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term pacemaker dependency and impact of pacing on mortality following transcatheter aortic valve replacement with the LOTUS valve.
    Alasti M; Rashid H; Rangasamy K; Kotschet E; Adam D; Alison J; Gooley R; Zaman S
    Catheter Cardiovasc Interv; 2018 Oct; 92(4):777-782. PubMed ID: 29314625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Procedural and 30-day clinical outcomes following transcatheter aortic valve replacement with lotus valve: Results of the RELEVANT study.
    Montone RA; Testa L; Fraccaro C; Montorfano M; Castriota F; Nerla R; Angelillis M; Tusa M; Giannini F; Garatti A; Tarantini G; Petronio AS; Brambilla N; Bedogni F
    Catheter Cardiovasc Interv; 2017 Dec; 90(7):1206-1211. PubMed ID: 28145039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of the fully repositionable and retrievable Boston Lotus and direct flow medical valves for the treatment of severe aortic stenosis: A single center experience.
    Giannini F; Latib A; Montorfano M; Ruparelia N; Romano V; Longoni M; Ferri L; Jabbour R; Mangieri A; Regazzoli D; Ancona M; Buzzatti N; Azzalini L; Tanaka A; Agricola E; Chieffo A; Alfieri O; Colombo A
    Catheter Cardiovasc Interv; 2018 Apr; 91(5):966-974. PubMed ID: 28941127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Procedural and thirty-day outcomes following transfemoral implantation of the fully repositionable and retrievable Lotus valve without routine pre-dilatation in a consecutive patient cohort: a single-center experience.
    Ruparelia N; Thomas K; Newton JD; Grebenik K; Keiralla A; Krasopoulos G; Sayeed R; Banning AP; Kharbanda RK
    Cardiovasc Revasc Med; 2018; 19(1 Pt B):78-82. PubMed ID: 29137967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence and predictors of permanent pacemaker implantation following treatment with the repositionable Lotus™ transcatheter aortic valve.
    Zaman S; McCormick L; Gooley R; Rashid H; Ramkumar S; Jackson D; Hui S; Meredith IT
    Catheter Cardiovasc Interv; 2017 Jul; 90(1):147-154. PubMed ID: 27862860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Importance of Contrast Aortography With Lotus Transcatheter Aortic Valve Replacement: A Post Hoc Analysis From the RESPOND Post-Market Study.
    van Gils L; Wöhrle J; Hildick-Smith D; Bleiziffer S; Blackman DJ; Abdel-Wahab M; Gerckens U; Brecker S; Bapat V; Modine T; Soliman OI; Nersesov A; Allocco D; Falk V; Van Mieghem NM
    JACC Cardiovasc Interv; 2018 Jan; 11(2):119-128. PubMed ID: 29348006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 1-Year Outcomes With the Fully Repositionable and Retrievable Lotus Transcatheter Aortic Replacement Valve in 120 High-Risk Surgical Patients With Severe Aortic Stenosis: Results of the REPRISE II Study.
    Meredith IT; Walters DL; Dumonteil N; Worthley SG; Tchétché D; Manoharan G; Blackman DJ; Rioufol G; Hildick-Smith D; Whitbourn RJ; Lefèvre T; Lange R; Müller R; Redwood S; Feldman TE; Allocco DJ; Dawkins KD
    JACC Cardiovasc Interv; 2016 Feb; 9(4):376-384. PubMed ID: 26892084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of Paravalvular Regurgitation After Implantation of the Fully Repositionable and Retrievable Lotus Transcatheter Aortic Valve (from the REPRISE II Trial Extended Cohort).
    Blackman DJ; Meredith IT; Dumonteil N; Tchétché D; Hildick-Smith D; Spence MS; Walters DL; Harnek J; Worthley SG; Rioufol G; Lefèvre T; Houle VM; Allocco DJ; Dawkins KD
    Am J Cardiol; 2017 Jul; 120(2):292-299. PubMed ID: 28535962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-Term Outcomes in Patients With New Permanent Pacemaker Implantation Following Transcatheter Aortic Valve Replacement.
    Chamandi C; Barbanti M; Munoz-Garcia A; Latib A; Nombela-Franco L; Gutiérrez-Ibanez E; Veiga-Fernandez G; Cheema AN; Cruz-Gonzalez I; Serra V; Tamburino C; Mangieri A; Colombo A; Jiménez-Quevedo P; Elizaga J; Laughlin G; Lee DH; Garcia Del Blanco B; Rodriguez-Gabella T; Marsal JR; Côté M; Philippon F; Rodés-Cabau J
    JACC Cardiovasc Interv; 2018 Feb; 11(3):301-310. PubMed ID: 29413244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Initial Experience of a Second-Generation Self-Expanding Transcatheter Aortic Valve: The UK & Ireland Evolut R Implanters' Registry.
    Kalra SS; Firoozi S; Yeh J; Blackman DJ; Rashid S; Davies S; Moat N; Dalby M; Kabir T; Khogali SS; Anderson RA; Groves PH; Mylotte D; Hildick-Smith D; Rampat R; Kovac J; Gunarathne A; Laborde JC; Brecker SJ
    JACC Cardiovasc Interv; 2017 Feb; 10(3):276-282. PubMed ID: 28183467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transfemoral aortic valve implantation is more successful with the Edwards Sapien 3 compared with the Edwards XT for the treatment of symptomatic severe aortic stenosis.
    Gonska B; Seeger J; Junker A; Rodewald C; Trepte U; Scharnbeck D; Rottbauer W; Wöhrle J
    Arch Cardiovasc Dis; 2018; 111(8-9):470-479. PubMed ID: 29128473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The interplay between permanent pacemaker implantation and mortality in patients treated by transcatheter aortic valve implantation: A systematic review and meta-analysis.
    Ueshima D; Nai Fovino L; Mojoli M; Napodano M; Fraccaro C; Tarantini G
    Catheter Cardiovasc Interv; 2018 Sep; 92(3):E159-E167. PubMed ID: 30019825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transfemoral aortic valve implantation with new-generation devices: the repositionable Lotus vs. the balloon-expandable Edwards Sapien 3 valve.
    Nai Fovino L; Badawy MRA; Fraccaro C; D'Onofrio A; Purita PAM; Frigo AC; Tellaroli P; Mauro A; Tusa M; Napodano M; Gerosa G; Iliceto S; Bedogni F; AbdelRheim AER; Tarantini G
    J Cardiovasc Med (Hagerstown); 2018 Nov; 19(11):655-663. PubMed ID: 30299408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of Direct Transcatheter Aortic Valve Replacement Without Balloon Aortic Valvuloplasty Using a New Generation Valve.
    Aalaei-Andabili SH; Beaver TM; Bavry AA; Petersen JW; Karimi A; Wayangankar S; Arnaoutakis G; Anderson RD
    Cardiovasc Revasc Med; 2019 Dec; 20(12):1100-1104. PubMed ID: 30826204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors and 5-Year Clinical Outcomes of Pacemaker After TAVR: Analysis From the PARTNER 2 SAPIEN 3 Registries.
    Chen S; Dizon JM; Hahn RT; Pibarot P; George I; Zhao Y; Blanke P; Kapadia S; Babaliaros V; Szeto WY; Makkar R; Thourani VH; Webb JG; Mack MJ; Leon MB; Kodali S; Nazif TM
    JACC Cardiovasc Interv; 2024 Jun; 17(11):1325-1336. PubMed ID: 38866455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and efficacy of a repositionable and fully retrievable aortic valve used in routine clinical practice: the RESPOND Study.
    Falk V; Wöhrle J; Hildick-Smith D; Bleiziffer S; Blackman DJ; Abdel-Wahab M; Gerckens U; Linke A; Ince H; Wenaweser P; Allocco DJ; Dawkins KD; Van Mieghem NM
    Eur Heart J; 2017 Dec; 38(45):3359-3366. PubMed ID: 28651336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors and clinical outcomes of permanent pacemaker implantation after transcatheter aortic valve replacement: the PARTNER (Placement of AoRtic TraNscathetER Valves) trial and registry.
    Nazif TM; Dizon JM; Hahn RT; Xu K; Babaliaros V; Douglas PS; El-Chami MF; Herrmann HC; Mack M; Makkar RR; Miller DC; Pichard A; Tuzcu EM; Szeto WY; Webb JG; Moses JW; Smith CR; Williams MR; Leon MB; Kodali SK;
    JACC Cardiovasc Interv; 2015 Jan; 8(1 Pt A):60-9. PubMed ID: 25616819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.